Clin2
NCT06338358Likely a fitNot yet recruiting

Understanding Participation Habits in Plaque Psoriasis

Plaque Psoriasis

Part of Skin clinical trials.

This study looks at how people with plaque psoriasis manage their condition and follow treatment plans. It aims to understand what helps or hinders participation, so researchers can improve care for others like you.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
500 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You have been diagnosed with plaque psoriasis (a skin condition causing red, scaly patches).
  • You are 18 years old or older.
  • You are willing to follow the study's rules, including attending appointments and taking any treatments as instructed.
  • If you are a woman who could become pregnant, you must have a negative pregnancy test before starting and not be breastfeeding.
  • You do not have any serious or unstable medical conditions that could affect your safety or the study results.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07129382Recruiting· Phase 1/Phase 2
Study of CS32582 for moderate to severe plaque psoriasis

This trial tests a new oral medication, CS32582, for people with moderate to severe plaque psoriasis. It aims to see if the drug is safe and effective at reducing skin symptoms like redness, thickness, and scaling.

Beijing, Beijing Municipality
NCT07251998Recruiting· Phase 2
A study of ICP-332 for moderate to severe plaque psoriasis

This trial tests an oral medication called ICP-332 versus a placebo (a pill with no active drug) for people with moderate to severe plaque psoriasis. The goal is to see if ICP-332 can improve skin symptoms and be safe.

Shanghai, Shanghai Municipality
NCT07024602Recruiting· Phase 1
Testing ASC50 tablets for plaque psoriasis

This study tests an investigational tablet called ASC50 for plaque psoriasis. It aims to see if it is safe and works well for people with this skin condition.

Miami, Florida
NCT07733089Recruiting· Phase 1
Testing a new psoriasis drug for safety and effect

This trial tests a new study drug (ZP9830) to see if it is safe and works well for people with plaque psoriasis. You would receive the treatment for 8 weeks, and the study will check how your skin responds.

Leiden, South Holland
NCT06643260Not yet recruiting· Phase 3
Study of oral piclidenoson for moderate-to-severe plaque psoriasis

This trial tests an oral medication called piclidenoson for people with moderate-to-severe plaque psoriasis. It aims to see if the drug is safe and effective at reducing skin symptoms.

NCT06579976Not yet recruiting
Ultrasound for measuring plaque psoriasis severity

This study uses a special ultrasound technique to get a better measure of how severe your plaque psoriasis is. It aims to see if this imaging can help doctors track the disease more accurately.

Shanghai, Shanghai Municipality

Hear when a new Plaque Psoriasis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.